CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
91-105 of 1225

Winning the CKD-aP Battle: A United Physician-Nurse Front
MinuteCE®Winning the CKD-aP Battle: A United Physician-Nurse Front

What You Don’t See: A Patient’s View of Living with CKD-aP
MinuteCE®What You Don’t See: A Patient’s View of Living with CKD-aP

Spotlight on Assessment: Tools That Capture CKD-aP
MinuteCE®Spotlight on Assessment: Tools That Capture CKD-aP

Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
CME/CEConference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice
- advertisement

Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice
CME/CEMenin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice

Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer

Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer

Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer

Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
MinuteCE®Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer
- advertisement

Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer
MinuteCE®Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer

Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice
CME/CERaising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice




































